{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:45:18Z","timestamp":1772246718241,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19 is characterized by strikingly large, mostly unexplained, interindividual variation in symptom severity: while some individuals remain nearly asymptomatic, others suffer from severe respiratory failure. Previous vaccinations for other pathogens, in particular tetanus, may partly explain this variation, possibly by readying the immune system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We made use of data on COVID-19 testing from 103,049 participants of the UK Biobank (mean age 71.5 years, 54.2% female), coupled to immunization records of the last ten years. Using logistic regression, covarying for age, sex, respiratory disease diagnosis, and socioeconomic status, we tested whether individuals vaccinated for tetanus, diphtheria or pertussis, differed from individuals that had only received other vaccinations on 1) undergoing a COVID-19 test, 2) being diagnosed with COVID-19, and 3) whether they developed severe COVID-19 symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that individuals with registered diphtheria or tetanus vaccinations are less likely to develop severe COVID-19 than people who had only received other vaccinations (diphtheria odds ratio (OR)=0.47, p-value=5.3*10\n                      <jats:sup>-5<\/jats:sup>\n                      ; tetanus OR=0.52, p-value=1.2*10\n                      <jats:sup>-4<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These results indicate that a history of diphtheria or tetanus vaccinations is associated with less severe manifestations of COVID-19. These vaccinations may protect against severe COVID-19 symptoms by stimulating the immune system. We note the correlational nature of these results, yet the possibility that these vaccinations may influence the severity of COVID-19 warrants follow-up investigations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2021.749264","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T23:56:29Z","timestamp":1634342189000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Diphtheria And Tetanus Vaccination History Is Associated With Lower Odds of COVID-19 Hospitalization"],"prefix":"10.3389","volume":"12","author":[{"given":"Jennifer","family":"Monereo-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurjen J.","family":"Luykx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justo","family":"Pinz\u00f3n-Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Motazedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars T.","family":"Westlye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An Interactive Web-Based Dashboard to Track COVID-19 in Real Time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.04.018","article-title":"The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review","volume":"78","author":"Nicola","year":"2020","journal-title":"Int J Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00242-7","article-title":"Urgent Needs of Low-Income and Middle-Income Countries for COVID-19 Vaccines and Therapeutics","volume":"397","author":"Figueroa","year":"2021","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"M20-6976","DOI":"10.7326\/M20-6976","article-title":"The Proportion of SARS-CoV-2 Infections That are Asymptomatic: A Systematic Review","volume":"22","author":"Oran","year":"2021","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9360","DOI":"10.3390\/ijerph17249360","article-title":"Clinical Profile, Treatment and Predictors During the First COVID-19 Wave: A Population-Based Registry Analysis From Castile and Leon Hospitals","volume":"17","author":"Guti\u00e9rrez-Abej\u00f3n","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41577-020-0351-0","article-title":"Risk Factors for Death From COVID-19","volume":"20","author":"Selvan","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-020-01242-z","article-title":"A Model of Disparities: Risk Factors Associated With COVID-19 Infection","volume":"19","author":"Rozenfeld","year":"2020","journal-title":"Int J Equity Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG Vaccination to Reduce the Impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.24.20042937","article-title":"Correlation Between Universal BCG Vaccination Policy and Reduced Mortality for COVID-19","author":"Miller","year":"2020","journal-title":"MedRxiv"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.07.005","article-title":"Could Bordetella Pertussis Vaccine Protect Against Coronavirus COVID-19","volume":"22","author":"Alkholy","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"B13","doi-asserted-by":"publisher","first-page":"109707","DOI":"10.1016\/j.mehy.2020.109707","article-title":"Is Global BCG Vaccination Coverage Relevant to the Progression of SARS-CoV-2 Pandemic","volume":"6","author":"Gursel","year":"2020","journal-title":"Med Hypotheses"},{"key":"B14","doi-asserted-by":"publisher","first-page":"110305","DOI":"10.1016\/j.mehy.2020.110305","article-title":"COVID-19 in Children: Could Pertussis Vaccine Play the Protective Role","volume":"145","author":"Ismail","year":"2020","journal-title":"Med Hypotheses"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00120","article-title":"Does Early Childhood Vaccination Protect Against COVID-19","volume":"7","author":"Sidiq","year":"2020","journal-title":"Front Mol Biosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12859-021-04045-3","article-title":"In Silico Comparative Study of SARS-CoV-2 Proteins and Antigenic Proteins in BCG, OPV, MMR and Other Vaccines: Evidence of a Possible Putative Protective Effect","volume":"22","author":"Haddad-Boubaker","year":"2021","journal-title":"BMC Bioinf"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.586984","article-title":"Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines","volume":"11","author":"Reche","year":"2020","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.31219\/osf.io\/sbgy3","article-title":"Cross-Reactive Immunity From Combination DTP Vaccines Could Protect Against COVID-19","author":"Reche","year":"2020","journal-title":"OSF Preprints"},{"key":"B19","doi-asserted-by":"publisher","first-page":"110395","DOI":"10.1016\/j.mehy.2020.110395","article-title":"Does Tetanus Vaccination Contribute to Reduced Severity of the COVID-19 Infection","volume":"146","author":"Rickett","year":"2021","journal-title":"Med Hypotheses"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2021.08.004","article-title":"Protective Heterologous T Cell Immunity in COVID-19 Induced by MMR and Tdap Vaccine Antigens","volume":"2","author":"Mysore","year":"2021","journal-title":"bioRxiv"},{"key":"B21","volume-title":"Immunisation Against Infectious Diseases","author":"Salisbury","year":"2006"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12822","article-title":"Adult Vaccination Against Tetanus and Diphtheria: The European Perspective","volume":"187","author":"Weinberger","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B23","unstructured":"UK Immunisation Schedule: The Green Book, Chapter 11"},{"key":"B24","article-title":"Tetanus Immunisation Policy in England and Wales\u2013an Overview of the Literature","volume":"7","author":"Bracebridge","year":"2004","journal-title":"Commun Dis Public Heal"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PloS Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s10900-020-00944-3","article-title":"The Impact of Socioeconomic Status on the Clinical Outcomes of COVID-19; a Retrospective Cohort Study","volume":"46","author":"Little","year":"2021","journal-title":"J Community Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.06.20092676","article-title":"Ethnicity, Comorbidity, Socioeconomic Status, and Their Associations With COVID-19 Infection in England: A Cohort Analysis of UK Biobank Data","author":"Prats-Uribe","year":"2020","journal-title":"medRxiv"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1192\/bjo.2020.75","article-title":"Associations Between Psychiatric Disorders, COVID-19 Testing Probability and COVID-19 Testing Results: Findings From a Population-Based Study","volume":"6","author":"van der Meer","year":"2020","journal-title":"BJPsych Open"},{"key":"B30","doi-asserted-by":"crossref","unstructured":"WickamH New YorkSpringerGgplot2: Elegant Graphics for Data Analysis2009","DOI":"10.1007\/978-0-387-98141-3"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.749264\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T02:52:57Z","timestamp":1699671177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.749264\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2021.749264"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.749264","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.09.21257809","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"article-number":"749264"}}